BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 46 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $58,000 | -73.6% | 17,600 | -69.5% | 0.00% | – |
| Q2 2021 | $220,000 | +144.4% | 57,679 | +144.4% | 0.00% | – |
| Q1 2021 | $90,000 | -35.3% | 23,604 | -23.4% | 0.00% | – |
| Q4 2020 | $139,000 | -30.5% | 30,807 | +72.9% | 0.00% | – |
| Q2 2020 | $200,000 | +55.0% | 17,820 | -36.1% | 0.00% | – |
| Q1 2020 | $129,000 | +138.9% | 27,878 | +101.7% | 0.00% | – |
| Q2 2018 | $54,000 | – | 13,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 3,586 | $15,000 | 0.01% |
| THOMPSON DAVIS & CO., INC. | 1,500 | $6,000 | 0.01% |
| Psagot Value Holdings Ltd. | 39,115 | $166,000 | 0.01% |
| GUARDIAN CAPITAL ADVISORS LP | 10,000 | $41,000 | 0.01% |
| Virtu KCG Holdings LLC | 41,537 | $177,000 | 0.01% |
| D'Orazio & Associates, Inc. | 1,000 | $4,000 | 0.00% |
| SIMPLEX TRADING, LLC | 7,703 | $32,000 | 0.00% |
| NORTHERN TRUST CORP | 34,223 | $145,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,180 | $9,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 73,366 | $311,000 | 0.00% |